Skip to main content
Medicover logo

Medicover — Investor Relations & Filings

Ticker · MCOV ISIN · SE0009778848 LEI · 5493000E9BUOYMOW2K53 ST Human health and social work activities
Open in API
Filings indexed 285 across all filing types
Latest filing 2017-10-27 Interim / Quarterly Rep…
Country SE Sweden
Listing ST MCOV

About Medicover

https://www.medicover.com/

Medicover is an international healthcare and diagnostic services provider. The company operates through two main divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division delivers a broad range of medical care, including primary care, specialist consultations, and hospital treatment. The Diagnostic Services division offers a comprehensive array of laboratory tests, from routine to advanced diagnostics, serving a wide network of clients. Committed to patient-centric care, Medicover focuses on quality, accessibility, and affordability by investing in modern medical technology and innovation. Its core mission is to improve and sustain the health and wellbeing of its customers.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT JULY–SEPTEMBER 2017' and provides comprehensive financial statements, including revenue, operating profit, net profit, and EBITDA for both the third quarter and the nine-month period. It includes detailed management commentary, segment analysis, and financial tables. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2017
2017-10-27 English
Medicover’s nomination committee for the AGM 2018
Board/Management Information Classification · 1% confidence The document is a short press release dated October 23, 2017, announcing the composition of the Nomination Committee for the upcoming Annual General Meeting (AGM) in 2018. It explicitly mentions the 'AGM 2018' and provides details about the committee members and submission deadlines for shareholder proposals related to the AGM. This content directly relates to the preparation and governance surrounding the Annual General Meeting. While it is an announcement, the specific nature of the content (Nomination Committee composition for the AGM) aligns most closely with governance materials related to the AGM, rather than a general Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the options, 'AGM Information' (AGM-R) is the most appropriate fit as it concerns materials related to the AGM.
2017-10-23 English
Medicovers valberedning inför årsstämman 2018
Regulatory Filings Classification · 1% confidence The document is a press release dated October 23, 2017, titled "MEDICOVERS VALBEREDNING INFÖR ÅRSSTÄMMAN 2018" (Medicover's Nomination Committee for the 2018 Annual General Meeting). It details the composition of the nomination committee appointed ahead of the 2018 AGM and provides instructions and deadlines for shareholders to submit proposals to this committee. This content directly relates to the preparation and governance surrounding the Annual General Meeting (AGM). While it is an announcement, the specific subject matter—the composition of the nomination committee—is a core component of AGM preparation and governance, making it closely related to AGM information or Governance Information. However, since it specifically discusses the committee *for* the AGM, and the AGM itself is a key event, it aligns best with the preparatory materials for the AGM. Given the options, it is most closely related to AGM preparation or Governance. Since it is an announcement about the committee composition for the upcoming AGM, and not a general governance report (CGR) or a proxy statement (PSI), it fits best under the general umbrella of AGM-related materials, although it is not the AGM presentation itself. Given the specific focus on the nomination committee for the AGM, and the lack of a specific 'Nomination Committee Announcement' code, I will classify it based on its relation to the AGM event. If it were a general board/management change, it would be MANG. Since it is about the committee selecting directors for the AGM, AGM-R is the most appropriate fit among the specific choices, as it is directly tied to the AGM process.
2017-10-23 Swedish
Acquisitions in India completed
M&A Activity Classification · 1% confidence The document is a short press release dated October 4, 2017, announcing the completion of two acquisitions in India for €18.5 million. It details the immediate accounting impact (consolidation of results). Crucially, it states that the information is made public pursuant to the EU Market Abuse Regulation and was submitted for publication. This is a specific corporate action announcement (M&A activity) that is not a full report (like 10-K or IR) and is more specific than a general Regulatory Filing (RNS). Since it details a merger/acquisition event, the most appropriate code is TAR (M&A Activity). The document length is very short (1386 chars), but the content is a direct announcement of a transaction, not just an announcement *about* a report, making TAR a better fit than RPA or RNS.
2017-10-04 English
Förvärven i Indien har slutförts
M&A Activity Classification · 1% confidence The document is a short press release (1377 characters) dated October 4, 2017, announcing the completion of previously announced acquisitions in India (Medicover Fertility India and MaxCure). It details the purchase price and consolidation dates. This type of announcement, concerning corporate actions like acquisitions, fits best under M&A Activity (TAR) or potentially a general Regulatory Filing (RNS) if TAR is too specific for a completion notice. However, since it directly relates to a significant corporate transaction (acquisition/takeover), TAR (Merger/Takeover Activity) is the most appropriate specific category, even though it's a completion notice rather than a proposal. Given the context of corporate actions, TAR is preferred over the general RNS.
2017-10-04 Swedish
Number of shares and votes in Medicover
Share Issue/Capital Change Classification · 1% confidence The document is a short press release dated September 29, 2017, announcing a change in the total number of shares and votes due to the conversion of Class A shares to Class B shares. This directly relates to the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes in capital structure. It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a dividend notice, director dealing, or earnings release. The length (1522 chars) is short, but the content is the primary announcement itself, not an announcement *about* another report, thus ruling out RPA/RNS based on the 'Menu vs Meal' rule for this specific content type.
2017-09-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.